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Clinics and pathology 
Disease 
T-cell acute lymphoblastic leukemia (T-ALL) 
Clinics 
Only two cases to date, a 5-year-old girl and a 8-year-
old boy (Su et al., 2004). 
Cytogenetics 
Cytogenetics morphological 
The rearrangement was cryptic. 





Transcription factor. TLX3 controls region-specific 
neuronal identities. TLX3 and TLX1 suppress 
GABAergic differentiation and promote glutamatergic 
dorsal horn neurons (Cheng et al., 2004). TLX3 and 
RUNX1 coordinate the development of a cohort of 
nociceptors, thermoceptors and pruriceptors (Lopes et 
al., 2012). TLX3 is required for proper formation of 
first-order relay visceral sensory neurons, especially 
involved in the physiologic control of cardiovascular 
and respiratory systems (Qian et al. 2001). TLX3 is 
upregulated by Wnt/beta-catenin signaling (Kondo et 
al., 2011). Calcium signaling regulates neurotransmitter 
specification.Calcium signaling involves 
phosphorylation of JUN that regulates TLX3 
transcription through a CRE site in its promoter (Marek 
et al., 2010). TLX3 has been found expressed in 60% 
of cases in a cohort of childhood T-cell ALL, but not in 
adult T-cell ALL cases nor in B-cell ALL cases 





Member of the CDK family; G1-phase kinase; CDK4 
and CDK6 are both partners of the 3 D-type cyclins 
(CCND1, CCND2, CCND3) to phosphorylate pRb; 
ubiquitously expressed; regulates cell-cycle progression 
through the G1 phase in proliferating cells; CDK4 and 
CDK6 are not completely redundant (Grossel and 
Hinds, 2006). 




Ectopic expression of TLX3. 
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